Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor
- PMID: 12196540
- DOI: 10.1074/jbc.M207135200
Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor
Abstract
The crystal structure of the kinase domain from the epidermal growth factor receptor (EGFRK) including forty amino acids from the carboxyl-terminal tail has been determined to 2.6-A resolution, both with and without an EGFRK-specific inhibitor currently in Phase III clinical trials as an anti-cancer agent, erlotinib (OSI-774, CP-358,774, Tarceva(TM)). The EGFR family members are distinguished from all other known receptor tyrosine kinases in possessing constitutive kinase activity without a phosphorylation event within their kinase domains. Despite its lack of phosphorylation, we find that the EGFRK activation loop adopts a conformation similar to that of the phosphorylated active form of the kinase domain from the insulin receptor. Surprisingly, key residues of a putative dimerization motif lying between the EGFRK domain and carboxyl-terminal substrate docking sites are found in close contact with the kinase domain. Significant intermolecular contacts involving the carboxyl-terminal tail are discussed with respect to receptor oligomerization.
Similar articles
-
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells.Cancer Res. 2004 Sep 15;64(18):6652-9. doi: 10.1158/0008-5472.CAN-04-1168. Cancer Res. 2004. PMID: 15374980
-
Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor.Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12022-7. doi: 10.1073/pnas.95.20.12022. Proc Natl Acad Sci U S A. 1998. PMID: 9751783 Free PMC article.
-
Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain.Biochem J. 2012 Dec 15;448(3):417-23. doi: 10.1042/BJ20121513. Biochem J. 2012. PMID: 23101586 Free PMC article.
-
Development of the epidermal growth factor receptor inhibitor Tarceva (OSI-774).Adv Exp Med Biol. 2003;532:235-46. doi: 10.1007/978-1-4615-0081-0_19. Adv Exp Med Biol. 2003. PMID: 12908562 Review.
-
Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.Pharmacol Res. 2019 Jan;139:395-411. doi: 10.1016/j.phrs.2018.11.014. Epub 2018 Nov 27. Pharmacol Res. 2019. PMID: 30500458 Review.
Cited by
-
In Vitro and Randomized Controlled Clinical Study of Natural Constituents' Anti-HPV Potential for Treatment of Plantar Warts Supported with In Silico Studies and Network Analysis.Pharmaceuticals (Basel). 2024 Jun 10;17(6):759. doi: 10.3390/ph17060759. Pharmaceuticals (Basel). 2024. PMID: 38931426 Free PMC article.
-
Unveiling the therapeutic potential of Canavalia rosea leaves: Exploring antioxidant, anti-inflammatory, anti-arthritic, and cytotoxic activities through biological and molecular docking evaluation with DFT analysis.Heliyon. 2024 Sep 26;10(19):e38541. doi: 10.1016/j.heliyon.2024.e38541. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39403519 Free PMC article.
-
Receptor-based virtual screening of EGFR kinase inhibitors from the NCI diversity database.Molecules. 2010 Jun 4;15(6):4041-54. doi: 10.3390/molecules15064041. Molecules. 2010. PMID: 20657425 Free PMC article.
-
The architecture of EGFR's basal complexes reveals autoinhibition mechanisms in dimers and oligomers.Nat Commun. 2018 Oct 18;9(1):4325. doi: 10.1038/s41467-018-06632-0. Nat Commun. 2018. PMID: 30337523 Free PMC article.
-
BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations.PLoS Med. 2007 Oct;4(10):1669-79; discussion 1680. doi: 10.1371/journal.pmed.0040315. PLoS Med. 2007. PMID: 17973572 Free PMC article.
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
